1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Blood Transfusion Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Blood Transfusion Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Blood Transfusion Diagnostics Market Regional Analysis
6.2 Europe Blood Transfusion Diagnostics Market Revenue 2020-2028 (US$ Million)
6.3 Europe Blood Transfusion Diagnostics Market Forecast Analysis
7. Europe Blood Transfusion Diagnostics Market Analysis – by Product
7.1 Instruments & Kits
- 7.1.1 Overview
- 7.1.2 Instruments & Kits: Europe Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Reagents
- 7.2.1 Overview
- 7.2.2 Reagents: Europe Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Europe Blood Transfusion Diagnostics Market Analysis – by Application
8.1 Blood Grouping
- 8.1.1 Overview
- 8.1.2 Blood Grouping: Europe Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Disease Screening
- 8.2.1 Overview
- 8.2.2 Disease Screening: Europe Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Europe Blood Transfusion Diagnostics Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Europe Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Diagnostic Laboratories: Europe Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Blood Banks
- 9.3.1 Overview
- 9.3.2 Blood Banks: Europe Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Plasma Fractionation Companies
- 9.4.1 Overview
- 9.4.2 Plasma Fractionation Companies : Europe Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. Europe Blood Transfusion Diagnostics Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Blood Transfusion Diagnostics Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.2.1.1 Europe Blood Transfusion Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe Blood Transfusion Diagnostics Market Breakdown, by Product
- 10.2.1.1.2 UK: Europe Blood Transfusion Diagnostics Market Breakdown, by Application
- 10.2.1.1.3 UK: Europe Blood Transfusion Diagnostics Market Breakdown, by End User
- 10.2.1.2 Germany:
Europe Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe Blood Transfusion Diagnostics Market Breakdown, by Product
- 10.2.1.2.2 Germany: Europe Blood Transfusion Diagnostics Market Breakdown, by Application
- 10.2.1.2.3 Germany: Europe Blood Transfusion Diagnostics Market Breakdown, by End User
- 10.2.1.3 France:
Europe Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe Blood Transfusion Diagnostics Market Breakdown, by Product
- 10.2.1.3.2 France: Europe Blood Transfusion Diagnostics Market Breakdown, by Application
- 10.2.1.3.3 France: Europe Blood Transfusion Diagnostics Market Breakdown, by End User
- 10.2.1.4 Russia:
Europe Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe Blood Transfusion Diagnostics Market Breakdown, by Product
- 10.2.1.4.2 Russia: Europe Blood Transfusion Diagnostics Market Breakdown, by Application
- 10.2.1.4.3 Russia: Europe Blood Transfusion Diagnostics Market Breakdown, by End User
- 10.2.1.5 Italy:
Europe Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe Blood Transfusion Diagnostics Market Breakdown, by Product
- 10.2.1.5.2 Italy: Europe Blood Transfusion Diagnostics Market Breakdown, by Application
- 10.2.1.5.3 Italy: Europe Blood Transfusion Diagnostics Market Breakdown, by End User
- 10.2.1.6 Rest of Europe:
Europe Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Blood Transfusion Diagnostics Market Breakdown, by Product
- 10.2.1.6.2 Rest of Europe: Europe Blood Transfusion Diagnostics Market Breakdown, by Application
- 10.2.1.6.3 Rest of Europe: Europe Blood Transfusion Diagnostics Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 BAG Diagnostics GmbH
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Bio-Rad Laboratories, Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 DiaSorin S.p.A.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Grifols, S.A.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Immucor, Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Ortho Clinical Diagnostics (QuidelOrtho Corporation)
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Quotient Limited
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations